Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Shao

Showing results (1-10 of 471) with videos related to

Pageof 48
Sort By:
Hepatology International|March 31, 2023
Another prognostic marker for hepatocellular carcinomaYu-Yun Shao
Yi Chuan = Hereditas|January 11, 2005
[Advances in the studies of molecular heredity of phenylketonuria]Zhi Zhang, Yun-Shao He
Journal of Ethnopharmacology|January 9, 2007
Fingerprinting quality control of Qianghuo by high-performance liquid chromatography-photodiode array detectionFuquan Jiang, Yanduo Tao, Yun Shao
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 15, 2010
[Expression and significance of bcl-2, bax, P53 in neuroendocrine carcinomas of the lung]Yun Shao, Po Zhao, Xianghong Li
Acta Cardiologica Sinica|March 15, 2021
Correspondence to: Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and UpdatesYu-Yun Shao, Hung-Ju Lin
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 28, 2026
Author reply to letters to the editor regarding "Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma" and corrigendumChing-Tso Chen, Yu-Yun Shao
Oral Oncology|August 27, 2010
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaYu-Yun Shao, Ruey-Long Hong
Anticancer Research|November 27, 2008
Fatal thrombocytopenia after oxaliplatin-based chemotherapyYu-Yun Shao, Ruey-Long Hong
Liver Cancer|October 9, 2025
Authors' Reply to the Letter "Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma"Yu-Yun Shao, Andrei R Akhmetzhanov
Liver Cancer|June 23, 2025
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical TrialsYu-Yun Shao, Andrei R Akhmetzhanov
Pageof 48

Showing results (1-10 of 471) with videos related to

Sort By:
Pageof 48
Hepatology International|March 31, 2023
Another prognostic marker for hepatocellular carcinomaYu-Yun Shao
Yi Chuan = Hereditas|January 11, 2005
[Advances in the studies of molecular heredity of phenylketonuria]Zhi Zhang, Yun-Shao He
Journal of Ethnopharmacology|January 9, 2007
Fingerprinting quality control of Qianghuo by high-performance liquid chromatography-photodiode array detectionFuquan Jiang, Yanduo Tao, Yun Shao
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 15, 2010
[Expression and significance of bcl-2, bax, P53 in neuroendocrine carcinomas of the lung]Yun Shao, Po Zhao, Xianghong Li
Acta Cardiologica Sinica|March 15, 2021
Correspondence to: Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and UpdatesYu-Yun Shao, Hung-Ju Lin
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 28, 2026
Author reply to letters to the editor regarding "Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma" and corrigendumChing-Tso Chen, Yu-Yun Shao
Oral Oncology|August 27, 2010
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaYu-Yun Shao, Ruey-Long Hong
Anticancer Research|November 27, 2008
Fatal thrombocytopenia after oxaliplatin-based chemotherapyYu-Yun Shao, Ruey-Long Hong
Liver Cancer|October 9, 2025
Authors' Reply to the Letter "Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma"Yu-Yun Shao, Andrei R Akhmetzhanov
Liver Cancer|June 23, 2025
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical TrialsYu-Yun Shao, Andrei R Akhmetzhanov
Pageof 48